311 related articles for article (PubMed ID: 18485512)
21. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
23. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
24. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
Toyota H; Yanase N; Yoshimoto T; Harada M; Kato Y; Mizuguchi J
Oncol Rep; 2015 Jan; 33(1):292-6. PubMed ID: 25394516
[TBL] [Abstract][Full Text] [Related]
25. A novel vaccine delivery system using immunopotentiating fusogenic liposomes.
Hayashi A; Nakanishi T; Kunisawa J; Kondoh M; Imazu S; Tsutsumi Y; Tanaka K; Fujiwara H; Hamaoka T; Mayumi T
Biochem Biophys Res Commun; 1999 Aug; 261(3):824-8. PubMed ID: 10441509
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model.
Kawakita A; Shirasaki H; Yasutomi M; Tokuriki S; Mayumi M; Naiki H; Ohshima Y
Allergy; 2012 Mar; 67(3):371-9. PubMed ID: 22423374
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
Okazaki S; Iwasaki T; Yuba E; Watarai S
J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
[TBL] [Abstract][Full Text] [Related]
28. [Immunological efficiency of DNA vaccine targeting dendritic cells against tumor].
Zhu B; Cheng XM; Duan YZ; Guo B; Wu YZ; Chen ZT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):239-42. PubMed ID: 16507263
[TBL] [Abstract][Full Text] [Related]
29. Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen.
Ikenaga T; Yamasaki Y; Shakushiro K; Nishikawa M; Takakura Y
Vaccine; 2004 Jun; 22(20):2609-16. PubMed ID: 15193386
[TBL] [Abstract][Full Text] [Related]
30. Sperm membrane lipid liposomes can evoke an effective immune response against encapsulated antigen in BALB/c mice.
Atif SM; Salam N; Ahmad N; Hasan IM; Jamal HS; Sudhanshu A; Azevedo V; Owais M
Vaccine; 2008 Oct; 26(46):5874-82. PubMed ID: 18789993
[TBL] [Abstract][Full Text] [Related]
31. Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.
Sprott GD; Dicaire CJ; Gurnani K; Deschatelets LA; Krishnan L
Vaccine; 2004 Jun; 22(17-18):2154-62. PubMed ID: 15149772
[TBL] [Abstract][Full Text] [Related]
32. Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant.
Li J; Guo J; Su Z; Hu M; Liu W; Wei Q
Int Immunol; 2011 May; 23(5):327-34. PubMed ID: 21447603
[TBL] [Abstract][Full Text] [Related]
33. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle.
Ikehara Y; Niwa T; Biao L; Ikehara SK; Ohashi N; Kobayashi T; Shimizu Y; Kojima N; Nakanishi H
Cancer Res; 2006 Sep; 66(17):8740-8. PubMed ID: 16951190
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
Shimizu Y; Takagi H; Nakayama T; Yamakami K; Tadakuma T; Yokoyama N; Kojima N
Parasite Immunol; 2007 May; 29(5):229-39. PubMed ID: 17430546
[TBL] [Abstract][Full Text] [Related]
35. Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex.
Nakamura T; Moriguchi R; Kogure K; Harashima H
Int J Pharm; 2013 Jan; 441(1-2):476-81. PubMed ID: 23159346
[TBL] [Abstract][Full Text] [Related]
36. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
37. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
[TBL] [Abstract][Full Text] [Related]
38. Requirement of TLR4 signaling for the induction of a Th1 immune response elicited by oligomannose-coated liposomes.
Matsuoka Y; Takagi H; Yamatani M; Kuroda Y; Sato K; Kojima N
Immunol Lett; 2016 Oct; 178():61-7. PubMed ID: 27485186
[TBL] [Abstract][Full Text] [Related]
39. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
